![Dong Zhou Liu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dong Zhou Liu
Directeur Général chez
HEIDELBERG PHARMA AG
Profil
Dong Zhou Liu currently works at Heidelberg Pharma AG, as Chief Executive Officer from 2025 and Huadong Medicine Co., Ltd., as CSO & President-Huadong Global Development.
Dr. Liu received his graduate degree from Long Island University and undergraduate degree and doctorate degree from Nankai University.
Postes actifs de Dong Zhou Liu
| Sociétés | Poste | Début |
|---|---|---|
| HEIDELBERG PHARMA AG | Directeur Général | 24/11/2025 |
| HUADONG MEDICINE CO., LTD | Directeur Technique/Scientifique/R&D | - |
Formation de Dong Zhou Liu
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
13
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Long Island University
 Long Island University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Heidelberg Pharma AG
 Heidelberg Pharma AG Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Health Technology |
Huadong Medicine Co., Ltd.
 Huadong Medicine Co., Ltd. Pharmaceuticals: MajorHealth Technology Produces traditional Chinese medicines and herbs | Health Technology |
Nankai University
 Nankai University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Choisissez Zonebourse 
